Language Select
Varian Logo

INVESTOR RELATIONS

 

Subscribe
Investor Meeting at ASTRO

Monday, September 16, 2019
2:00pm CT
Listen to Webcast
Presentation

Varian Updates Investors on Proposed Reimbursement Changes

Thursday, August 8, 2019

Presentation

Third Quarter FY2019 Earnings Results Conference Call

Wednesday, July 24, 2019
1:30pm PDT

Listen to Webcast
Presentation
 

Investor Information

Recent News
Sep 16, 2019
Varian Names Chief Medical Officer for Interventional Oncology

Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September...

Sep 16, 2019
Varian Ranked Highest in Survey of US Radiation Oncology Professionals

Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally,...

Sep 16, 2019
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System

Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-room system available for...

More news >


Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5631
E-mail: investors@varian.com
IR Contacts

NYSE: VAR
NYSEVAR
  • Follow Us

© 1999-2019 Varian Medical Systems, Inc.
All Rights reserved.

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo